Literature DB >> 17901411

Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness.

Teal S Hallstrand1, Emil Y Chi, Alan G Singer, Michael H Gelb, William R Henderson.   

Abstract

RATIONALE: Secreted phospholipase A(2) enzymes (sPLA(2)s) play key regulatory roles in the biosynthesis of eicosanoids, such as the cysteinyl leukotrienes, but the role of these enzymes in the pathogenesis of asthma is not known.
OBJECTIVES: To establish if sPLA(2)s are overexpressed in the airways of patients with asthma, and to determine if these enzymes may play a role in the generation of eicosanoids in exercise-induced bronchoconstriction.
METHODS: Induced sputum samples were obtained from subjects with asthma with exercise-induced bronchoconstriction and nonasthmatic control subjects at baseline, and on a separate day 30 minutes after exercise challenge. The expression of the PLA(2)s in induced sputum cells and supernatant was determined by quantitative polymerase chain reaction, immunocytochemistry, and Western blot.
MEASUREMENTS AND MAIN RESULTS: The sPLA(2)s expressed at the highest levels in airway cells of subjects with asthma were groups X and XIIA. Group X sPLA(2) (sPLA(2)-X) was differentially overexpressed in asthma and localized to airway epithelial cells and bronchial macrophages. The gene expression, immunostaining in airway epithelial cells and bronchial macrophages, and the level of the extracellular sPLA(2)-X protein in the airways increased in response to exercise challenge in the asthma group, whereas the levels were lower and unchanged after challenge in nonasthmatic control subjects.
CONCLUSIONS: Increased expression of sPLA(2)-X may play a key role in the dysregulated eicosanoid synthesis in asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901411      PMCID: PMC2176098          DOI: 10.1164/rccm.200707-1088OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  52 in total

1.  Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics.

Authors:  D L Bowton; M C Seeds; M B Fasano; B Goldsmith; D A Bass
Journal:  Am J Respir Crit Care Med       Date:  1997-02       Impact factor: 21.405

2.  Transcellular eicosanoid synthesis in cocultures of alveolar epithelial cells and macrophages.

Authors:  M Peters-Golden; A Feyssa
Journal:  Am J Physiol       Date:  1993-05

3.  Role of cytosolic phospholipase A2 in allergic response and parturition.

Authors:  N Uozumi; K Kume; T Nagase; N Nakatani; S Ishii; F Tashiro; Y Komagata; K Maki; K Ikuta; Y Ouchi; J Miyazaki; T Shimizu
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

4.  Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.

Authors:  L A Marshall; B Bolognese; J D Winkler; A Roshak
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

5.  A novel calcium-independent phospholipase A2, cPLA2-gamma, that is prenylated and contains homology to cPLA2.

Authors:  K W Underwood; C Song; R W Kriz; X J Chang; J L Knopf; L L Lin
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

6.  Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.

Authors:  E Melillo; K L Woolley; P J Manning; R M Watson; P M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  1994-05       Impact factor: 21.405

7.  The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men.

Authors:  C C Hardy; C Robinson; A E Tattersfield; S T Holgate
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

8.  Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects.

Authors:  M S Balter; W L Eschenbacher; M Peters-Golden
Journal:  Am Rev Respir Dis       Date:  1988-11

9.  Characterization of phospholipase A2 from human nasal lavage.

Authors:  J M Stadel; K Hoyle; R M Naclerio; A Roshak; F H Chilton
Journal:  Am J Respir Cell Mol Biol       Date:  1994-07       Impact factor: 6.914

10.  Antigen-induced generation of lyso-phospholipids in human airways.

Authors:  F H Chilton; F J Averill; W C Hubbard; A N Fonteh; M Triggiani; M C Liu
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  43 in total

1.  Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X.

Authors:  Ying Lai; Rob C Oslund; James G Bollinger; William R Henderson; Luis F Santana; William A Altemeier; Michael H Gelb; Teal S Hallstrand
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2.

Authors:  Francescopaolo Granata; Annunziata Frattini; Stefania Loffredo; Rosaria I Staiano; Angelica Petraroli; Domenico Ribatti; Rob Oslund; Michael H Gelb; Gerard Lambeau; Gianni Marone; Massimo Triggiani
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

Review 3.  An update on exercise-induced bronchoconstriction with and without asthma.

Authors:  Chris Randolph
Journal:  Curr Allergy Asthma Rep       Date:  2009-11       Impact factor: 4.806

4.  Group X secretory phospholipase A2 enhances TLR4 signaling in macrophages.

Authors:  Preetha Shridas; William M Bailey; Kayla R Talbott; Rob C Oslund; Michael H Gelb; Nancy R Webb
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

Review 5.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

6.  Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

Authors:  Daniele De Luca; Angelo Minucci; Enrico Zecca; Marco Piastra; Domenico Pietrini; Virgilio P Carnielli; Cecilia Zuppi; Ascanio Tridente; Giorgio Conti; Ettore D Capoluongo
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

7.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

8.  Randomized controlled trial of fish oil and montelukast and their combination on airway inflammation and hyperpnea-induced bronchoconstriction.

Authors:  Sandra Tecklenburg-Lund; Timothy D Mickleborough; Louise A Turner; Alyce D Fly; Joel M Stager; Gregory S Montgomery
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

9.  Identification of Epithelial Phospholipase A2 Receptor 1 as a Potential Target in Asthma.

Authors:  James D Nolin; H Luke Ogden; Ying Lai; William A Altemeier; Charles W Frevert; James G Bollinger; Gajendra S Naika; Anthony Kicic; Stephen M Stick; Gerard Lambeau; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

10.  Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes.

Authors:  Teal S Hallstrand; Mark M Wurfel; Ying Lai; Zhanglin Ni; Michael H Gelb; William A Altemeier; Richard P Beyer; Moira L Aitken; William R Henderson
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.